Sponsored by:

Molecular Imaging: Page 514

Draxis names president of radiopharmaceuticals group
Draxis Health of Mississauga, Ontario, has selected Jean-Pierre Robert as the new president of its radiopharmaceuticals division in Montreal.
April 26, 2005
MRI studies make sense of multifaceted schizophrenia
By Shalmali Pal
The myth of multiple personalities aside, schizophrenia is a complex disorder. Specific diagnoses can range from paranoid schizophrenia to catatonia to undifferentiated schizophrenia. Several recent studies have applied MRI to clarify this mental illness.
April 26, 2005
PET/CT makes inroads in lung cancer staging
By Shalmali Pal
April 25, 2005
Isotope Product Laboratories, Battelle join forces
By AuntMinnie.com staff writers
Calibration-source developer Isotope Product Laboratories (IPL) has signed a collaborative agreement with science and technology enterprise Battelle to develop a radiopharmaceutical-grade 68Ge/68Ga radionuclide generating system.
April 25, 2005
More PET/CT lung masses seen with hardware-based fusion
By Eric Barnes
Two new studies underscore the superiority of PET/CT for imaging lung lesions compared to either modality alone. The first found that different fusion methods produce substantially different results, while the second found that PET/CT has higher sensitivity, specificity, and positive and negative predictive values than either modality alone for detecting lung metastases.
April 25, 2005
2005 04 25 15 10 14 706
AuntMinnie.com Molecular Imaging Radiology Insider
By Jonathan S. Batchelor
April 24, 2005
PET/CT market on the rise
By AuntMinnie.com staff writers
The U.S. PET and PET/CT markets produced revenue of $496.6 million in 2004, according to a new report from market research firm Frost & Sullivan.
April 24, 2005
SPECT reveals sharply higher cardiac risk within metabolic syndrome
By Tracie L. Thompson
Metabolic syndrome patients who also have ischemia on a stress SPECT exam are dealing with more than an added risk to their health. In fact, the likelihood of short-term death or heart attack for such patients is multiplied.
April 21, 2005
Neoprobe inks new Lymphoseek deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe of Dublin, OH, has signed an agreement with the University of California, San Diego that will enable the company to expand its Lymphoseek radiopharmaceutical into applications in ultrasound and optical imaging.
April 20, 2005
GE inks drug-discovery pact with Eli Lilly
By AuntMinnie.com staff writers
Multimodality vendor GE Healthcare of Chalfont St. Giles, U.K., has signed an agreement with pharmaceutical developer Eli Lilly of Indianapolis covering research into compounds that could be developed into diagnostic and therapeutic agents for Alzheimer's disease.
April 19, 2005
Molecular Insight raises $28 million
By AuntMinnie.com staff writers
Radioisotope imaging developer Molecular Insight Pharmaceuticals of Cambridge, MA, said it has raised $28 million in Series C financing.
April 19, 2005
Philips installs first hybrid SPECT/CT units
By AuntMinnie.com staff writers
Multimodality vendor Philips Medical Systems of Andover, MA, has completed the first installations of its Precedence hybrid SPECT/CT systems.
April 18, 2005
Previous Page
Page 514 of 615
Next Page